학술논문

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants.
Document Type
Article
Source
Pediatric Infectious Disease Journal; Aug2020, Vol. 39 Issue 8, p763-770, 8p
Subject
Language
ISSN
08913668